Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Merck And Co Inc (MRK)

2014-10-31@16:18:10 ET
Imago BioSciences secures $26.5 million in Series A financing (DTF)

2014-10-31@15:01:59 ET
German National Day celebrations in Taipei (ABW)

2014-10-31@13:11:22 ET
Merck (MRK) Trading Near $58.49 Resistance Level (FBM)

2014-10-31@10:48:24 ET
Merck (MRK) Crosses Pivot Point Resistance at $57.90 (F79)

2014-10-31@10:33:35 ET
Merck (MRK) Approaches New Upside Target of $58.49 (PSM)

2014-10-31@08:00:00 ET
Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures (PRN)

2014-10-31@04:55:01 ET
Research and Markets: Global Pediatric Vaccine Market 2014-2018: Key Vendors are GlaxoSmithKline, Merck, Pfizer and Sanofi (BIZ)

2014-10-31@04:37:52 ET
Global Pediatric Vaccine Market 2014-2018: Key Vendors are GlaxoSmithKline, Merck, Pfizer and Sanofi (MTO)

2014-10-31@03:51:03 ET
Q&A: New research integrity director says animal abuse citations are "something in the past" (UNW)

2014-10-30@21:28:32 ET
Q&A: New research integrity director says animal abuse citations are "something in the past" (UNW)

2014-10-30@13:55:51 ET
Top 5 Performing Dow Stocks (V, MRK, PFE, KO, TRV) (F70)

2014-10-30@09:15:00 ET
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire (PRN)

2014-10-30@08:22:37 ET
Potential Merck (MRK) Trade Has 4.07% Downside Protection (FBM)

2014-10-30@06:12:35 ET
Merck Forms a Scientific Partnership with Kenya Medical Research Institute (KEMRI) as part of its Capacity Advancement Program in Africa (ABW)

2014-10-30@01:03:25 ET
Merck Posts Third-Quarter Results (CLM)

2014-10-30@01:03:20 ET
FDA Grants Breakthrough Therapy Designation to Keytruda (CLM)

2014-10-29@15:00:02 ET
Merck (MRK) Showing Resistance Near $58.02 (FBM)

2014-10-29@12:33:04 ET
Merck Forms a Scientific Partnership with Kenya Medical Research Institute (KEMRI) as part of its Capacity Advancement Program in Africa (MTO)

2014-10-29@12:00:00 ET
The Market for Non-Small-Cell Lung Cancer Will Grow to $8.5 Billion in 2023, Driven by the Entry of Thirteen Novel Drugs (PRN)